de Melo Gagliato, D.; C Buzaid, A.; Perez-Garcia, J.M.; Llombart, A.; Cortes, J.
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge. Cancers 2020, 12, 2480.
https://doi.org/10.3390/cancers12092480
AMA Style
de Melo Gagliato D, C Buzaid A, Perez-Garcia JM, Llombart A, Cortes J.
CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge. Cancers. 2020; 12(9):2480.
https://doi.org/10.3390/cancers12092480
Chicago/Turabian Style
de Melo Gagliato, Debora, Antonio C Buzaid, Jose Manuel Perez-Garcia, Antonio Llombart, and Javier Cortes.
2020. "CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge" Cancers 12, no. 9: 2480.
https://doi.org/10.3390/cancers12092480
APA Style
de Melo Gagliato, D., C Buzaid, A., Perez-Garcia, J. M., Llombart, A., & Cortes, J.
(2020). CDK4/6 Inhibitors in Hormone Receptor-Positive Metastatic Breast Cancer: Current Practice and Knowledge. Cancers, 12(9), 2480.
https://doi.org/10.3390/cancers12092480